ELLIPSE A/S: Financial statements 2020
CVR: 20560673
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ELLIPSE A/S (CVR 20560673) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 12,899,465 and a net result of DKK 3,862,898 compared with DKK 105,441,899 the year before. That is a decrease of 88.9% compared with the year before. Equity in the 2020 report amounted to DKK 148,451,029. The solvency ratio was 87.8%. The company had 35 employees in the financial year.
- Gross Profit
- DKK 12,899,465
- Profit/Loss
- DKK 3,862,898
- Equity
- DKK 148,451,029
- Total Assets
- DKK 169,124,028
- Employees
- 35
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 12.9 mio. | 3.9 mio. | 148.5 mio. | 35 |
| 2019 | - | 115.9 mio. | 105.4 mio. | 144.6 mio. | 30 |
| 2018 | - | 43.9 mio. | -117 t. | 39.1 mio. | 35 |
| 2017 | - | 36.6 mio. | 10.5 mio. | 37.7 mio. | 35 |
| 2016 | - | 29.6 mio. | 8.1 mio. | 34.2 mio. | 32 |
Official annual report
How creditworthy is ELLIPSE A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ELLIPSE A/S has published its annual report for 2019. Gross profit came to DKK 115,908,209, and the net result was DKK 105,441,899.
About ELLIPSE A/S
ELLIPSE A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 1997. The company has been dissolved on 30 April 2025. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company was previously named 3D - DANISH DERMATOLOGIC DEVELOPMENT A/S. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 1,300,672 and a net result of DKK -24,466,572 compared with DKK 1,121,861 the year before. Equity in the 2023 report amounted to DKK 40,227,789.